Fox Foundation Grant to Help Advance CNM-Au8 to Planned Phase 2 Trial

A grant from the Michael J. Fox Foundation (MJFF) will help Clene Nanomedicine to advance in development CNM-Au8, its cellular energy-promoting, investigational Parkinson’s treatment. The grant will help to support preclinical studies in patients’ nerve cells and mouse models of the disease, as well as facilitate the launch of a Phase 2 safety and effectiveness…

Blood Pressure and Prostate Treatment May Prevent or Slow Parkinson’s, Early Study Suggests

People taking Hytrin (terazosin) or similar medications to treat high blood pressure and benign prostatic hyperplasia may be less likely to develop Parkinson’s disease, an early study suggests. Parkinson’s patients who use these medications may also see their disease progress more slowly and with fewer complications, its researchers report.